期刊文献+

淋巴瘤微环境的研究进展 被引量:1

Progress of Studies on Microenvironment of Lymphoma——Review
下载PDF
导出
摘要 诸多研究表明,淋巴瘤的发生与染色体易位、参与细胞周期和凋亡途径的分子改变有关。但是,T细胞和B细胞肿瘤细胞的生存同样依赖于这些细胞与组成淋巴瘤微环境的诸多细胞的相互作用。淋巴瘤微环境由不同的免疫细胞、辅助基质细胞及众多分子组成,与肿瘤细胞相互作用促进肿瘤的生长和药物耐药。淋巴瘤是一类异质性很强的疾病,不同类型间预后差别很大,而其微环境对此起着重要的作用。本文阐述了近来研究较多的组成淋巴瘤微环境的细胞及分子成分,包括巨噬细胞、黏附分子及趋化因子,以及微环境在经典型霍奇金淋巴瘤、滤泡性淋巴瘤及弥漫大B细胞淋巴瘤中所起的作用,显示微环境对淋巴瘤预后的影响及针对肿瘤微环境来治疗淋巴瘤的新途径。 Many studies indicate that lymphoid neoplasms are related with chromosome translocations and the molecular alterations involving in the cell cycle and/or apoptotic pathways.However,survival of B and T tumor cells also depends on interactions of these cells with the accompanying cells comprising the lymphoma microenvironment.Immune cells,stromal cells and numerous moleculars together make up the microenvironment and have functional interaction with tumor cells,promoting tumor growth and drug resistance.Different types of lymphoma have various clinical courses,therapy responses and prognoses,which show a close relationship with the microenvironment.This review summarizes several components of lymphoma microenvironment including macrophages,adhesion molecules and chemokines and the roles of microenvironment in classic non-Hodgkin′s lymphoma,follicular lymphoma,diffuse large B-cell lymphoma,suggesting that the microenvironment influence the prognosis of lymphoma,targeting microenvi-ronment may be a potential method in lymphoma therapy.
出处 《中国实验血液学杂志》 CAS CSCD 2011年第5期1310-1313,共4页 Journal of Experimental Hematology
关键词 淋巴瘤 淋巴瘤微环境 肿瘤微环境 lymphoma lymphoma microenvironment tumor microenvironment
  • 相关文献

参考文献34

  • 1Herreros B, Sanchez-Aguilera A, Piris MA. Lymphoma microenvironment: culprit or innocent? Leukemia, 2008; 22( 1 ): 49- 58.
  • 2Sanchez-Beato M, Sanchez-Aguilera A, Piris MA. Cell cycle deregulation in B-cell lymphomas. Blood, 2003; 101 (4) : 1220 - 1235.
  • 3Alvaro T, Lejeune M, Camacho FI, et al. The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma. Haematologica, 2006; 91(12) :1605 - 1612.
  • 4Ostrowski MC. Cytokines in the Tumor Stroma. In: Caligiuri MA, Lotze MT. Cytokines in the genesis and trea- tment of cancer, NJ: Humana Press Inc. 2007 : 233 - 244.
  • 5Farinha P, Masoudi H, Skinnider BF, et al. Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood, 2005; 106(6): 2169-2174.
  • 6Canioni D, Salles G, Mounier N, et al. High numbers of tumor- associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial. J Clin Oncol, 2008 ; 26 ( 3 ) : 440 - 446.
  • 7Taskinen M, Karjalainen-Lindsberg ML, Nyman H, et al. A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclopho- sphamide-doxorubicin-vincristine-pred-nisone. Clin Cancer Res, 2007; 13(19) : 5784 -5789.
  • 8Lejeune M, Alvaro T. Clinicobiological, prognostic and therapeutic implications of the tumor microenvironment in follicular lymphoma. Haematologica, 2009 ; 94( 1 ) : 16 - 21.
  • 9Steidl C, Lee T, Shah SP, et al. Tumor-associated macrophages and survival in classic Hodgking lymphoma. N Engl J Med, 2010 ; 362 (10) : 875 - 885.
  • 10Kurtova AV, Tamayo AT, Ford R J, et al. Mantle cell lymphoma cells express high levels of CXCR4, CXCRS, and VLA-4 ( CD49d ): importance for interactions with the stromal microenvironment and specific targeting. Blood, 2009 ; 113 ( 19 ) : 4604 -4613.

同被引文献30

  • 1ANSELL S M. Hodgkin lymphoma: 2012 update on diagnosis, risk-stratification, and management[J]. Am J Hematol, 2012,87(12) 11096-1103.
  • 2EBERLE F C, MANI H, JAFFE E S. Histopathology of Hodgkin's lymphoma[J]. Cancer J, 2009,15(2):129- 137.
  • 3MANI H, JAFFE E S. Hodgkin lymphoma: an update on its biology with new insights into classification[J]. Clin Lymphoma Myeloma, 2009,9 (3) : 206-216.
  • 4ALDINUCCI D, GLOGHINI A, PINTO A, et al. The classical Hodgkin's lymphoma micro environment and its role in promoting tumor growth and immune escape[J]. J Pathol,2010,221(3):248-263.
  • 5COTTA C V,COLEMAN J F,LI S,et al. Nodular lymphocyte predominant Hodgkin lymphoma and diffuse large B-cell lymphoma : a study of six cases concurrently involving the same site[J]. Histopathology, 2011,59(6):1194- 1203.
  • 6KUPPERS R. The biology of Hodgkin's lymphoma[J]. Nat Rev Cancer, 2009,9 (1) : 15-27.
  • 7CATTARUZZA L, GLOGHINI A, OLIVO K, et al. Functional coexpression of Interleukin (IL)-7 and its rece- ptor (IL-7R) on Hodgkin and Reed-Sternberg cells: Involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma[J]. Int J Cancer, 2009,125 (5) : 1092-1101.
  • 8ANDERSSON E, SCHAIN F, SJOBERG J, et al. Interleukin-13 stimulation of the mediastinal B-cell lymphoma cell line Karpas-ll06P induces a phenotype resembling the Hodgkin lymphoma cell line L1236[J]. Exp Hematol, 2010,38(2) :116-123.
  • 9SCHEEREN F A, DIEHL S A, SMIT L A, et al. IL-21 is expressed in Hodgkin lymphoma and activates STA- T5: evidence that activated STAT5 is required for Hodgkin lymphomagenesis[J]. Blood, 2008, 111 (9):4706- 4715.
  • 10ALDINUCCI D, RAPANA' B, OLIVO K, et al. IRF4 is modulated by CD40L and by apoptotic and anti-proli- ferative signals in Hodgkin lymphoma [J]. Br J Haematol, 2010,148(1):115-118.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部